Fused tricyclic drug patent granted, Mar 31
Summary
Fused tricyclic drug patent granted, Mar 31
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Fused tricyclic derivative and pharmaceutical application thereof
Grant US12590082B2 Kind: B2 Mar 31, 2026
Assignee
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
Inventors
Peng Zhang, Yunfu Luo, Feng Gao, Shuhui Chen
Abstract
Disclosed are a fused tricyclic derivative and a pharmaceutical application thereof. Specifically disclosed are a compound represented by formula (III) and a pharmaceutically acceptable salt thereof.
CPC Classifications
C07D 409/14 C07D 413/14 C07D 487/04 C07D 491/048 C07D 491/056 C07D 491/107
Filing Date
2021-09-28
Application No.
18027049
Claims
20
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.